Description
Global Human identification Market Industry Overview
The global human identification market is projected to reach $6,435.6 million by 2032 from $1,385.8 million in 2021, at a CAGR of 14.77% during the forecast period 2022-2032. The growth in the global human identification market is expected to be driven by the increasing adoption of NGS in various research fields, high adoption of forensic applications, and technological advancements in the field of molecular techniques and diagnostics tests.
Market Lifecycle Stage
Human identification is widely used in forensics, paternity testing, disaster victim identification, and anthropology, among other applications, with DNA analysis/profiling being a key tool in this sector. Due to increasing demands on time and resources, human identification and forensics labs are under constant pressure to increase the efficiency of their workflows without sacrificing quality.
Examining the variety of biological indicators that are available to investigators illustrates the basic principles of each process in criminal investigation and paternity identification. While DNA and fingerprints are clearly the favored methods of identification, they require a prior record and verifiable baseline for comparison. Further remarkable advancements in the field of genomics, proteomics, molecular biology, data analytics, and technical engineering have paved the way for the development of advanced NGS-based technologies, such as SNP and STR sequencing.
The impressive research on molecular technologies and biomarkers using NGS has unlocked pathways for the development of various momentous procedures such as mtDNA sequencing. The growing demand for non-invasive diagnostic procedures enabling genetic profiling has further enhanced the requirement for NGS technologies.
Acknowledging the future potential for massive growth in demand for non-invasive diagnostic procedures, several biotechnology companies such as Illumina, Inc., Thermo Fisher Scientific, and Agilent Technologies, Inc. have invested substantially to aid further developments in forensics technologies.
Impact
• Increasing demand for human identification products/technologies is anticipated to support the growth of the global human identification market during the forecast period 2022-2032.
• The market is expected to grow at a significant growth rate due to opportunities such as the high adoption of forensic applications in the field of computational biology and technological advancements in the field of molecular techniques and diagnostics tests.
Impact of COVID-19
The current global human identification market comprises various applications such as forensic applications, paternity applications, and other applications. It has been noticed that there has been a reduction in the capacity or shutdowns of laboratories and other research institutions, which has led to reduced usage of various products and services related to research.
The government imposed various restrictions during COVID-19, such as travel bans, quarantines, curfews, business shutdowns, and closures. This led to an increased cost of the COVID-19-related services. There have been many issues during the COVID-19 pandemic, such as operational failures, shipping issues, inaccurate demand forecasts, and other production issues.
Furthermore, the health and the safety of employees were impacted as COVID-19 reduced the efficacy of employees’ work potential. However, the market related to COVID-19 grew during the pandemic as customers were in need of testing services. Overall, the impact of COVID-19 on the market size has been low-moderate.
Some market players have reported a slight decline in sales. However, financials are already on their way to recovery. The decline in revenues was mostly a result of the initial phases of the COVID-19 pandemic, which comprised complete lockdowns across countries and major cities, thus interrupting the supply chain.
The timeline of impact spanned the end of the first quarter and the second quarter of 2020 for most key markets across the globe. However, the pandemic has played a key role in enhancing the growth prospects of human identification and is expected to indirectly aid in improving the market growth outlook.
Market Segmentation:
Segmentation 1: by Offering
• Product
• Service
The service segment held the largest share, 55.47%, of the global human identification market in 2021. This trend is expected to continue during the forecast period 2022-2032, with the segment anticipated to hold a 53.00% share in 2032. The high share of the services segment is majorly due to the rising demand for human identification services in paternity testing procedures, the rising number of product launches and approval in recent years, and increasing emphasis on the adoption of human identification technologies.
Segmentation 2: by Technology
• Next-Generation Sequencing (NGS)
• Polymerase Chain Reaction (PCR)
• Capillary Electrophoresis
• Nucleic Acid Extraction and Purification (Magnetic Bead Technology)
• Rapid DNA Analysis
• Other Technologies
In 2021, the global human identification market (by technology) was dominated by PCR, with a massive market share of 41.00%. This trend is expected to continue during the forecast period 2022-2032, with the segment anticipated to hold a 37.11% share in 2032. This is primarily due to the growing incidences of violent crime leading to growth in demand for rapid DNA analysis in forensics testing.
Segmentation 3: by Application
• Forensic Application
• Paternity Identification
• Other Applications
In 2021, the global human identification market (by application) was dominated by forensic applications, with a massive market share of 61.88%. This trend is expected to continue during the forecast period 2022-2032, with the segment anticipated to hold a 62.11% share in 2032.
Segmentation 4: by End User
• Forensic Laboratories and Law Enforcement Agencies
• Academic and Research Institutions
• Hospitals and Healthcare Providers
The forensic laboratories and law enforcement agencies segment dominate the global human identification market. Academic and research institutions are among the primary end-users of human identification. Research organizations constitute integral facilities for companies as well as independent academic research facilities.
Segmentation 5: by Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Rest-of-the-World
The North America region is expected to dominate the global human identification market during the forecast period 2022-2032. North America has a high adoption rate of forensic testing kits and services. Backed by several healthcare companies working in the marketplace, the U.S. has the highest implementation of PCR, NGS, and other technologies. The North America region is expected to reach $3,526.7 million in 2032 from $737.7 million in 2021, at a CAGR of 15.07% during the forecast period.
Recent Developments in the Global Human identification Market
• Partnership: In 2021, QIAGEN partnered with Verogen, Inc. to provide superior tools and comprehensive support for forensic biometric identification workflows in the laboratories.
• Product Launch: In 2021, QIAGEN launched the EZ2 Connect Instrument Line that will speed the benefits of biomedical research, forensics, and clinical diagnostics.
• Product Launch: In 2022, Promega Corporation launched Spectrum CE System for performing human identification in criminal casework and database cases in forensic laboratories.
Demand – Drivers and Limitations
Following are the demand drivers for the human identification market:
• Increasing Demand for Human Identification Products/Technologies
• High Adoption of Forensic Applications in the Field of Computational Biology
• Technological Advancements in Molecular Techniques and Forensic Tests
The market is expected to face some limitations too due to the following challenges:
• Lack of Forensic Testing Infrastructure
• High Capital Requirement Hampering the Expansion of Global Reach
How Can This Report Add Value to an Organization?
Product/Innovation Strategy: Product launches and upgrades in the human identification industry are aimed at advancing the overall technologies in the market to ensure efficient detection of various applications such as forensic and paternity identification. Several companies, including Thermo Fisher Scientific Inc., and QIAGEN N.V. were involved in product innovations.
Competitive Strategy: Enterprises led by the market juggernauts frequently update their product portfolios with innovative and application-specific products to sustain current market competition. Moreover, a detailed competitive benchmarking of the players operating in the global human identification market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.
Key Market Players and Competition Synopsis
The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.
Some of the prominent names established in this market are:
• Abbott.
• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Eurofins Scientific
• Promega Corporation
• Illumina, Inc.
• Laboratory Corporation of America Holdings
• PerkinElmer Inc.
• QIAGEN N.V.
• Thermo Fisher Scientific Inc.
• Verogen, Inc.
• NMS Labs
• AUTOGEN INC.
• GENETEK BIOPHARMA GmbH
• SecuriGene Technologies Inc.
Table of Contents
1 Market
1.1 Product Definition
1.2 Inclusion and Exclusion
2 Market Scope
2.1 Key Questions Answered in the Report
3 Research Methodology
3.1 Data Sources
3.1.1 Primary Data Source
3.1.2 Secondary Data Sources
3.2 Market Estimation Model
3.3 Criteria for Company Profiling
4 Market Overview
4.1 Introduction
4.2 Evolution in Forensic Science
4.3 Approaches for Human Identification: Biological Approach
4.4 Global Human Identification Market, 2022-2032
4.5 COVID-19 Impact on Global Human Identification Market
4.5.1 Impact on Market
5 Industry Insights
5.1 Regulatory Framework
5.1.1 Regulatory Framework in the U.S
5.1.1.1 Guidelines Recommendation
5.1.2 Regulatory Framework in the U.S. for Medical Devices
5.1.2.1 Regulation Framework for Medical Devices Used in Human Identification
5.2 Legal Requirements and Framework in Asia-Pacific
5.2.1.1 China
5.2.1.2 Japan
5.2.1.2.1 Pharmaceuticals and Medical Devices Agency (PMDA)
6 Market Dynamics
6.1 Market Drivers
6.1.1 Increasing Demand for Human Identification Products/Technologies
6.1.2 High Adoption of Data Analytics and Computational Biology in Forensic Applications in the Field of Computational Biology
6.1.3 Technological Advancements in Molecular Techniques and Forensic Tests
6.2 Market Challenges
6.2.1 Lack of Forensic Testing Infrastructure
6.2.2 High Capital Requirement Hampering the Expansion of Global Reach
6.3 Market Opportunities
6.3.1 Massive Scope for Adoption of NGS and Capillary Electrophoresis Based Forensic Products in Emerging Nations
6.3.2 Increased Research Funding for Executing Research and Development Exercise
7 Competitive Insights
7.1 Corporate Strategies
7.1.1 Synergistic Activities
7.1.2 Business Expansion
7.2 Business Strategies
7.2.1 Service/Product Launches
7.3 Market Share Analysis (by Product Manufacturer)
7.4 Market Share Analysis (by Service Provider)
8 Global Human Identification Market, by Offering, $Million, 2021-2032
8.1 Overview
8.2 Product
8.2.1 Assay and Kit
8.2.1.1 DNA Amplification Kit
8.2.1.2 DNA Quantification Kit
8.2.1.3 DNA Extraction Kit
8.2.1.4 Rapid DNA Analysis Kit
8.2.2 Instrument
8.2.2.1 DNA Collection System
8.2.2.2 Electrophoresis System
8.2.2.3 Thermal Cycler
8.2.2.4 Rapid DNA Analysis System
8.2.2.5 NGS Platform
8.2.2.6 Microarray Scanner
8.2.2.7 Other Instruments
8.2.3 Software
8.2.3.1 Analytical Software
8.2.3.2 Data Interpretation
8.2.3.3 Data Storage
8.3 Service
9 Global Human Identification Market, by Technology, $Million, 2021-2032
9.1 Overview
9.2 Next-Generation Sequencing (NGS)
9.2.1 SNP and STR Sequencing
9.2.2 mtDNA Sequencing
9.3 Polymerase Chain Reaction (PCR)
9.3.1 Digital PCR
9.3.2 Real-Time PCR
9.4 Capillary Electrophoresis
9.5 Nucleic Acid Extraction and Purification (Magnetic Bead Technology)
9.6 Rapid DNA Analysis Technology
9.7 Other Technologies
10 Global Human Identification Market, by Application, $Million, 2021-2032
10.1 Overview
10.2 Forensic Application
10.2.1 Crime and Sexual Assault Investigation
10.2.2 Missing Person Investigation
10.2.3 Disaster Victim Identification
10.2.4 Others
10.3 Paternity Identification
10.3.1 Paternity and Kinship Testing
10.3.2 Genetic Testing
10.4 Other Application
11 Global Human Identification Market, by End User, $Million, 2021-2032
11.1 Overview
11.1.1 Forensic Laboratories and Law Enforcement Agencies
11.1.2 Academic and Research Institutions
11.1.3 Hospitals and Healthcare Providers
12 Global Human Identification Market, By Region, $Million, 2021-2032
12.1 Overview
12.2 North America
12.2.1 U.S.
12.2.2 Canada
12.3 Europe
12.3.1 Germany
12.3.2 France
12.3.3 U.K.
12.3.4 Italy
12.3.5 Spain
12.3.6 Rest-of-Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 Australia
12.4.5 South Korea
12.4.6 Rest-of-Asia-Pacific
12.5 Latin America
12.5.1 Brazil
12.5.2 Mexico
12.5.3 Rest-of-Latin America
12.6 Rest-of-the-World
13 Market - Company Profiles
13.1 Overview
13.2 Abbott.
13.2.1 Company Overview
13.2.2 Role of Abbott. in the Global Human Identification Market
13.2.3 Key Competitors of the Company
13.2.4 Financials
13.2.5 Key Insights about the Financial Health of the Company
13.2.6 Analyst’s Perspective
13.3 Agilent Technologies, Inc.
13.3.1 Company Overview
13.3.2 Role of Agilent Technologies, Inc. in the Global Human Identification Market
13.3.3 Key Competitors of the Company
13.3.4 Financials
13.3.5 Key Insights about the Financial Health of the Company
13.3.6 Analyst’s Perspective
13.4 Bio-Rad Laboratories, Inc.
13.4.1 Company Overview
13.4.2 Role of Bio-Rad Laboratories, Inc. in the Global Human Identification Market
13.4.3 Key Competitors of the Company
13.4.4 Key Customers of the Company
13.4.5 Financials
13.4.6 Key Insights about the Financial Health of the Company
13.4.7 Analyst’s Perspective
13.5 Eurofins Scientific
13.5.1 Company Overview
13.5.2 Role of Eurofins Scientific in the Global Human Identification Market
13.5.3 Key Competitors of the Company
13.5.4 Key Customers of the Company
13.5.1 Business Strategies
13.5.2 Financials
13.5.3 Analyst’s Perspective
13.6 Promega Corporation
13.6.1 Company Overview
13.6.2 Role of Promega Corporation in the Global Human Identification Market
13.6.3 Key Customers of the Company
13.6.4 Key Competitors of the Company
13.6.5 Business Strategies
13.6.6 Analyst’s Perspective
13.7 Illumina, Inc.
13.7.1 Company Overview
13.7.2 Role of Illumina, Inc. in the Global Human Identification Market
13.7.3 Key Competitors of the Company
13.7.4 Financials
13.7.5 Key Insights about the Financial Health of the Company
13.7.6 Analyst’s Perspective
13.8 Laboratory Corporation of America Holdings
13.8.1 Company Overview
13.8.2 Role of Laboratory Corporation of America Holdings in the Global Human identification Market
13.8.3 Key Competitors of the Company
13.8.4 Financials
13.8.5 Analyst’s Perspective
13.9 PerkinElmer Inc.
13.9.1 Company Overview
13.9.2 Role of PerkinElmer Inc. in the Global Human Identification Market
13.9.3 Key Competitors of the Company
13.9.4 Financials
13.9.5 Key Insights about the Financial Health of the Company
13.9.6 Analyst’s Perspective
13.1 QIAGEN N.V.
13.10.1 Company Overview
13.10.2 Role of QIAGEN N.V. in the Global Human Identification Market
13.10.3 Key Competitors of the Company
13.10.4 Key Customers of the Company
13.10.5 Corporate Strategies
13.10.6 Business Strategies
13.10.7 Financials
13.10.8 Key Insights about the Financial Health of the Company
13.10.9 Analyst’s Perspective
13.11 Thermo Fisher Scientific Inc.
13.11.1 Company Overview
13.11.2 Role of Thermo Fisher Scientific Inc. in the Global Human Identification Market
13.11.3 Key Customers of the Company
13.11.4 Key Competitors of the Company
13.11.5 Corporate Strategies
13.11.6 Business Strategies
13.11.7 Financials
13.11.8 Key Insights about the Financial Health of the Company
13.11.9 Analyst’s Perspective
13.12 Verogen, Inc.
13.12.1 Company Overview
13.12.2 Role of Verogen, Inc. in the Global Human Identification Market
13.12.3 Key Competitors of the Company
13.12.4 Key Customers of the Company
13.12.5 Business Strategies
13.12.6 Analyst’s Perspective
13.13 NMS Labs
13.13.1 Company Overview
13.13.2 Role of NMS Labs in the Global Human Identification Market
13.13.3 Key Competitors of the Company
13.13.4 Corporate Strategies
13.13.5 Analyst’s Perspective
13.14 AUTOGEN INC.
13.14.1 Company Overview
13.14.2 Role of AUTOGEN INC. in the Global Human Identification Market
13.14.3 Business Strategies
13.14.4 Analyst’s Perspectives
13.15 GENETEK BIOPHARMA GmbH
13.15.1 Company Overview
13.15.2 Role of GENETEK BIOPHARMA GmbH in the Global Human Identification Market
13.15.3 Analyst’s Perspectives
13.16 SecuriGene Technologies Inc.
13.16.1 Company Overview
13.16.2 Role of SecuriGene Technologies Inc. GmbH in the Global Human Identification Market
13.16.3 Analyst’s Perspectives
List of Figures
Figure 1: Sexual Offences in the U.S., 2019-2022
Figure 2: NIH Funding, 2019-2022
Figure 3: Global Human Identification Market Dynamics
Figure 4: Global Human Identification Market (by Offering), $Million, 2021 and 2032
Figure 5: Global Human Identification Market (by Application), $Million, 2021 and 2032
Figure 6: Global Human Identification Market (by Technology), $Million, 2021 and 2032
Figure 7: Global Human Identification Market (by End User), $Million, 2021 and 2032
Figure 8: Global Human identification Market (by Region), $Million, 2021
Figure 9: Global Human Identification Market: Market Segmentation
Figure 10: Global Human Identification Market Research Methodology
Figure 11: Primary Research Methodology
Figure 12: Bottom-Up Approach (Segment-Wise Analysis)
Figure 13: Top-Down Approach (Segment-Wise Analysis)
Figure 14: Different Steps in Forensics Technology
Figure 15: Evolution in Forensic Investigation
Figure 16: Workflow for Forensic Procedures
Figure 17: Dominating Segments of the Global Human Identification Market, 2021 and 2032
Figure 18: Global Human Identification Market, $Million, 2021-2032
Figure 19: Pre-COVID-19 and Post-COVID-19 Scenario of Global Human Identification Market, 2020-2026
Figure 20: Impact of COVID-19 on Human Identification Market
Figure 21: Responsibilities of the National Medical Products Administration (NMPA)
Figure 22: Global Human Identification Market Dynamics
Figure 23: Total Violent Crime Reported in the U.S., 2015-2020
Figure 24: NIH Funding, 2019-2022
Figure 25: Share of Key Developments and Strategies, January 2019-May 2022
Figure 26: Synergistic Activities Share (by Company), January 2019-May 2022
Figure 27: Service/Product Launches (by Company), January 2019-May 2022
Figure 28: Global Human Identification Market Share Analysis (by Product Manufacturer), 2020 and 2021
Figure 29: Global Human Identification Market Share Analysis (by Service Provider), 2020 and 2021
Figure 30: Global Human Identification Market (by Offering)
Figure 31: Share of Global Human Identification Market (by Offering), $Million, 2021 and 2032
Figure 32: Share of Global Human Identification Market (by Product), $Million, 2021 and 2032
Figure 33: Global Human Identification Market (Product), $Million, 2021-2032
Figure 34: Global Human Identification Market (Assay and Kit), $Million, 2021-2032
Figure 35: Global Human Identification Market (DNA Amplification Kit), $Million, 2021-2032
Figure 36: Global Human Identification Market (DNA Quantification Kit), $Million, 2021-2032
Figure 37: Global Human Identification Market (DNA Extraction Kit), $Million, 2021-2032
Figure 38: Global Human Identification Market (Rapid DNA Analysis Kit), $Million, 2021-2032
Figure 39: Global Human Identification Market (Instrument), $Million, 2021-2032
Figure 40: Global Human Identification Market (DNA Collection System), $Million, 2021-2032
Figure 41: Global Human Identification Market (Electrophoresis System), $Million, 2021-2032
Figure 42: Global Human Identification Market (Thermal Cycler), $Million, 2021-2032
Figure 43: Global Human Identification Market (Rapid DNA Analysis System), $Million, 2021-2032
Figure 44: Global Human Identification Market (NGS Platform), $Million, 2021-2032
Figure 45: Global Human Identification Market (Microarray Scanner), $Million, 2021-2032
Figure 46: Global Human Identification Market (Other Instruments), $Million, 2021-2032
Figure 47: Global Human Identification Market (Software), $Million, 2021-2032
Figure 48: Global Human Identification Market (Analytical Software), $Million, 2021-2032
Figure 49: Global Human Identification Market (Data Interpretation), $Million, 2021-2032
Figure 50: Global Human Identification Market (Data Storage), $Million, 2021-2032
Figure 51: Global Human Identification Market (Service), $Million, 2021-2032
Figure 52: Global Human Identification Market (by Technology), $Million, 2021 and 2032
Figure 53: Global Human Identification Market (Next-Generation Sequencing), $Million, 2021-2032
Figure 54: Global Human Identification Market (SNP and STR Sequencing), $Million, 2021-2032
Figure 55: Global Human Identification Market (mtDNA Sequencing), $Million, 2021-2032
Figure 56: Application of PCR
Figure 57: Global Human Identification Market (Polymerase Chain Reaction), $Million, 2021-2032
Figure 58: Global Human Identification Market (Digital PCR), $Million, 2021-2032
Figure 59: Global Human Identification Market (Real-Time PCR), $Million, 2021-2032
Figure 60: Global Human Identification Market (Capillary Electrophoresis), $Million, 2021-2032
Figure 61: Global Human Identification Market Nucleic Acid Extraction and Purification (Magnetic Bead Technology), $Million, 2021-2032
Figure 62: Global Human Identification Market (Rapid DNA Analysis Technology), $Million, 2021-2032
Figure 63: Global Human Identification Market (Other Technologies), $Million, 2021-2032
Figure 64: Global Human Identification Market (by Application)
Figure 65: Global Human Identification Market (by Application), $Million, 2021 and 2032
Figure 66: Global Human Identification Market (Crime And Sexual Assault Investigation), $Million, 2021-2032
Figure 67: Global Human Identification Market (Missing Person Investigation), $Million, 2021-2032
Figure 68: Global Human Identification Market (Disaster Victim Identiifcation), $Million, 2021-2032
Figure 69: Global Human Identification Market (Others), $Million, 2021-2032
Figure 70: Global Human identification Market (Paternity Identification), $Million, 2021-2032
Figure 71: Global Human Identification Market (Paternity and Kinship Testing), $Million, 2021-2032
Figure 72: Global Human Identification Market (Genetic Testing), $Million, 2021-2032
Figure 73: Global Human identification Market (Other Application), $Million, 2021-2032
Figure 74: Global Human Identification Market (by End User), 2021 vs. 2032
Figure 75: Global Human Identification Market (by Forensic Laboratories and Law enforcement Agencies), $Million, 2021-2032
Figure 76: Global Human Identification Market (Academic and Research Institutions), $Million, 2021-2032
Figure 77: Global Human Identification Market (Hospitals and Healthcare Providers), $Million, 2021-2032
Figure 78: Global Human identification Market (by Region), $Million, 2021-2032
Figure 79: North America Human Identification Market (by Country), 2021 vs. 2032
Figure 80: North America Human Identification Market, $Million, 2021-2032
Figure 81: Market Dynamics of North America Human Identification Market
Figure 82: U.S. Human Identification Market, $Million, 2021-2032
Figure 83: U.S. Human Identification Market (by Technology), $Million, 2021-2032
Figure 84: U.S. Human Identification Market (by Offering), $Million, 2021-2032
Figure 85: U.S. Human Identification Market (by Product), $Million, 2021-2032
Figure 86: Canada Human Identification Market, $Million, 2021-2032
Figure 87: Canada Human Identification Market (by Technology), $Million, 2021-2032
Figure 88: Canada Human Identification Market (by Offering), $Million, 2021-2032
Figure 89: Canada Human Identification Market (by Product), $Million, 2021-2032
Figure 90: Europe Human Identification Market (by Country), 2021 vs. 2032
Figure 91: Europe Human Identification Market, $Million, 2021-2032
Figure 92: Market Dynamics of the Europe Human identification Market
Figure 93: Germany Human Identification Market, 2021-2032
Figure 94: Germany Human Identification Market (by Technology), $Million, 2021-2032
Figure 95: Germany Human Identification Market (by Offering), $Million, 2021-2032
Figure 96: Germany Human Identification Market (by Product), $Million, 2021-2032
Figure 97: France Human Identification Market, $Million, 2021-2032
Figure 98: France Human Identification Market (by Technology), $Million, 2021-2032
Figure 99: France Human Identification Market (by Offering), $Million, 2021-2032
Figure 100: France Human Identification Market (by Product), $Million, 2021-2032
Figure 101: U.K. Human Identification Market, $Million, 2021-2032
Figure 102: Sexual Assault Cases Trends in the U.K
Figure 103: U.K. Human Identification Market (by Technology), $Million, 2021-2032
Figure 104: U.K. Human Identification Market (by Offering), $Million, 2021-2032
Figure 105: U.K. Human Identification Market (by Product), $Million, 2021-2032
Figure 106: Italy Human Identification Market, $Million 2021-2032
Figure 107: Italy Human Identification Market (by Technology), $Million, 2021-2032
Figure 108: Italy Human Identification Market (by Offering), $Million, 2021-2032
Figure 109: Italy Human Identification Market (by Product), $Million, 2021-2032
Figure 110: Spain Human Identification Market, $Million, 2021-2032
Figure 111: Spain Human Identification Market (by Technology), $Million, 2021-2032
Figure 112: Spain Human Identification Market (by Offering), $Million, 2021-2032
Figure 113: Spain Human Identification Market (by Product), $Million, 2021-2032
Figure 114: Rest-of-Europe Human Identification Market, $Million, 2021-2032
Figure 115: Rest-of-Europe Human Identification Market (by Technology), $Million, 2021-2032
Figure 116: Rest-of-Europe Human Identification Market (by Offering), $Million, 2021-2032
Figure 117: Rest-of-Europe Human Identification Market (by Product), $Million, 2021-2032
Figure 118: Asia-Pacific Human Identification Market (by Country), 2021 vs. 2032
Figure 119: Asia-Pacific Human Identification Market, $Million, 2021-2032
Figure 120: Market Dynamics of the Asia-Pacific Human Identification Market
Figure 121: China Human Identification Market, $Million, 2021-2032
Figure 122: China Human Identification Market (by Technology), $Million, 2021-2032
Figure 123: China Human Identification Market (by Offering), $Million, 2021-2032
Figure 124: China Human Identification Market (by Product), $Million, 2021-2032
Figure 125: Japan Human Identification Market, $Million, 2021-2032
Figure 126: Japan Human Identification Market (by Technology), $Million, 2021-2032
Figure 127: Japan Human Identification Market (by Offering), $Million, 2021-2032
Figure 128: Japan Human Identification Market (by Product), $Million, 2021-2032
Figure 129: India Human Identification Market, $Million, 2021-2032
Figure 130: India Human Identification Market (by Technology), $Million, 2021-2032
Figure 131: India Human Identification Market (by Offering), $Million, 2021-2032
Figure 132: India Human Identification Market (by Product), $Million, 2021-2032
Figure 133: Australia Human Identification Market, $Million, 2021-2032
Figure 134: Australia Human Identification Market (by Technology), $Million, 2021-2032
Figure 135: Australia Human Identification Market (by Offering), $Million, 2021-2032
Figure 136: Australia Human Identification Market (by Product), $Million, 2021-2032
Figure 137: South Korea Human Identification Market, $Million, 2021-2032
Figure 138: South Korea Human Identification Market (by Technology), $Million, 2021-2032
Figure 139: South Korea Human Identification Market (by Offering), $Million, 2021-2032
Figure 140: Australia Human Identification Market (by Product), $Million, 2021-2032
Figure 141: Rest-of-Asia-Pacific Human Identification Market, 2021-2032
Figure 142: Rest-of-Asia-Pacific Human Identification Market (by Technology), $Million, 2021-2032
Figure 143: Rest-of-Asia-Pacific Human Identification Market (by Offering), $Million, 2021-2032
Figure 144: Rest-of-Asia-Pacific Human Identification Market (by Product), $Million, 2021-2032
Figure 145: Latin America Human Identification Market (by Country), 2021 vs. 2032
Figure 146: Latin America Human Identification Market, $Million, 2021-2032
Figure 147: Market Dynamics of Latin America Human Identification Market
Figure 148: Brazil Human Identification Market, $Million, 2021-2032
Figure 149: Brazil Human Identification Market (by Technology), $Million, 2021-2032
Figure 150: Brazil Human Identification Market (by Offering), $Million, 2021-2032
Figure 151: Brazil Human Identification Market (by Product), $Million, 2021-2032
Figure 152: Mexico Human Identification Market, 2021-2032
Figure 153: Mexico Human Identification Market (by Technology), $Million, 2021-2032
Figure 154: Mexico Human Identification Market (by Offering), $Million, 2021-2032
Figure 155: Mexico Human Identification Market (by Product), $Million, 2021-2032
Figure 156: Rest-of-Latin America Human Identification Market, 2021-2032
Figure 157: Rest-of-Latin America Human Identification Market (by Technology), $Million, 2021-2032
Figure 158: Rest-of-Latin America Human Identification Market (by Offering), $Million, 2021-2032
Figure 159: Rest-of-Latin America Human Identification Market (by Product), $Million, 2021-2032
Figure 160: Rest-of-the-World Human Identification Market, $Million, 2021-2032
Figure 161: Total Number of Companies Profiled
Figure 162: Abbott.: Overall Product Portfolio
Figure 163: Abbott.: Overall Financials, $Million, 2019-2021
Figure 164: Abbott.: Revenue (by Segment), $Million, 2019-2021
Figure 165: Abbott.: Revenue (by Region), $Million, 2019-2021
Figure 166: Abbott.: R&D Expenditure, $Million, 2019-2021
Figure 167: Agilent Technologies, Inc.: Overall Product Portfolio
Figure 168: Agilent Technologies, Inc.: Overall Financials, $Million, 2019-2021
Figure 169: Agilent Technologies, Inc.: Revenue (by Segment), $Million, 2019-2021
Figure 170: Agilent Technologies, Inc.: Revenue (by Region), $Million, 2019-2021
Figure 171: Agilent Technologies, Inc.: R&D Expenditure, $Million, 2019-2021
Figure 172: Bio-Rad Laboratories, Inc.: Overall Product Portfolio
Figure 173: Bio-Rad Laboratories, Inc.: Overall Financials, $Million, 2019-2021
Figure 174: Bio-Rad Laboratories, Inc.: Revenue (by Segment), $Million, 2019-2021
Figure 175: Bio-Rad Laboratories, Inc.: Revenue (by Region), $Million, 2019-2021
Figure 176: Bio-Rad Laboratories, Inc.: R&D Expenditure, $Million, 2019-2021
Figure 177: Eurofins Scientific: Product Portfolio
Figure 178: Eurofins Scientific: Overall Financials, $Million, 2019-2021
Figure 179: Eurofins Scientific: Revenue (by Region), $Million, 2019-2021
Figure 180: Promega Corporation.: Product Portfolio
Figure 181: Illumina, Inc.: Product Portfolio
Figure 182: Illumina, Inc.: Overall Financials, $Million, 2019-2021
Figure 183: Illumina, Inc.: Revenue (by Segment), $Million, 2019-2021
Figure 184: Illumina, Inc.: Revenue (by Region), $Million, 2019-2021
Figure 185: Illumina, Inc.: R&D Expenditure, $Million, 2019-2021
Figure 186: Laboratory Corporation of America Holdings: Overall Product Portfolio
Figure 187: Laboratory Corporation of America Holdings: Overall Financials, $Million, 2019-2021
Figure 188: Laboratory Corporation of America Holdings: Revenue (by Segment), $Million, 2019-2021
Figure 189: Laboratory Corporation of America Holdings: Revenue (by Region), $Million, 2019-2021
Figure 190: PerkinElmer Inc.: Product Portfolio
Figure 191: PerkinElmer Inc.: Overall Financials, $Million, 2019-2021
Figure 192: PerkinElmer Inc.: Revenue (by Segment), $Million, 2019-2021
Figure 193: PerkinElmer Inc.: Revenue (by Region), $Million, 2019-2021
Figure 194: PerkinElmer Inc.: R&D Expenditure, $Million, 2019-2021
Figure 195: QIAGEN N.V.: Overall Product Portfolio
Figure 196: QIAGEN N.V.: Overall Financials, $Million, 2019-2021
Figure 197: QIAGEN N.V.: Revenue (by Segment), $Million, 2019-2021
Figure 198: QIAGEN N.V.: Revenue (by Region), $Million, 2019-2021
Figure 199: QIAGEN N.V.: R&D Expenditure, $Million, 2019-2021
Figure 200: Thermo Fisher Scientific Inc.: Product Portfolio
Figure 201: Thermo Fisher Scientific Inc.: Overall Financials, $Million, 2019-2021
Figure 202: Thermo Fisher Scientific Inc.: Revenue (by Segment), $Million, 2019-2021
Figure 203: Thermo Fisher Scientific Inc.: Revenue (by Region), $Million, 2019-2021
Figure 204: Thermo Fisher Scientific Inc.: R&D Expenditure, $Million, 2019-2021
Figure 205: Verogen, Inc.: Product Portfolio
Figure 206: NMS Labs: Product Portfolio
Figure 207: AUTOGEN INC. Product Portfolio
Figure 208: GENETEK BIOPHARMA GmbH: Product Portfolio
Figure 209: SecuriGene Technologies Inc.: Product Portfolio
List of Tables
Table 1: COVID-19 Impact on Global Human Identification Market
Table 2: Products Launched by Various Key Players for Human Identification Research
Table 3: The following table indicates an underlying dominance of product launches and technologies that took place from 2021.Product Development, 2021
Table 4: Key Players and Its Products
Table 5: Pricing List of Key Players’ Human Identification
Table 6: Key Players and Its Products
Table 7: Some of Companies Providing Products
Table 8: Some of Companies Providing DNA Amplification Kit
Table 9: Some of Companies Providing DNA Quantification Kit
Table 10: Some of Companies Providing DNA Extraction Kit
Table 11: Some of Companies Providing DNA Collection System
Table 12: Some of Companies Providing Electrophoresis System
Table 13: Some of Companies Providing Thermal Cycler
Table 14: Some of Companies Providing Rapid DNA Analysis System
Table 15: Some of Companies Offering NGS Platform
Table 16: Some of Companies Providing Microarray Scanner
Table 17: Some of Companies Providing Software
Table 18: Some of Companies Providing Service
Table 19: Example of Products Based on Next-Generation Sequencing
Table 20: Example of Products Based on SNP and STR Sequencing
Table 21: Example of Products Based on mtDNA Sequencing
Table 22: List of Products Based on Digital PCR
Table 23: Examples of Products Based on Real-Time PCR
Table 24: List of Products Based on Capillary Electrophoresis
Table 25: Example of Products Providing Nucleic Acid Extraction and Purification (Based on Magnetic Bead Technology)
Table 26: List of Products Based on Rapid DNA Analysis Technology
Table 27: List of Service Based on Other Technologies
Companies Mentioned
Abbott.
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Eurofins Scientific
Promega Corporation
Illumina, Inc.
Laboratory Corporation of America Holdings
PerkinElmer Inc.
QIAGEN N.V.
Thermo Fisher Scientific Inc.
Verogen, Inc.
NMS Labs
AUTOGEN INC.
GENETEK BIOPHARMA GmbH
SecuriGene Technologies Inc.
Reviews
There are no reviews yet.